pharmexec.com
/1 month ago
Latest updates for <![Cdata[Fda]]>
Fresh curated links around are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- <![CDATA[FDA Pannel Votes to Loosen Restrictions for Four Peptides ]]>
- <![CDATA[What Moments in FDA’s Review Process Should Patients and Providers be Watching Closely?]]>
- <![CDATA[What FDA's Peptide Decision Means for the Industry]]>
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
pharmexec.com
/6 days ago
<![CDATA[What Moments in FDA’s Review Process Should Patients and Providers be Watching Closely?]]>
pharmexec.com
/1 month ago
<![CDATA[What FDA's Peptide Decision Means for the Industry]]>
pharmexec.com
/1 month ago
<![CDATA[Why FDA is Sending an Increased Number of Drug Warning Letters]]>
pharmexec.com
/3 weeks ago
<![CDATA[AI at the FDA: Efficiency, Oversight, and Open Questions]]>
pharmexec.com
/1 month ago
<![CDATA[Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides]]>
pharmexec.com
/2 weeks ago
<![CDATA[Pharmaceutical Executive Daily: FDA Approves Pasatru]]>
pharmexec.com
/2 weeks ago
<![CDATA[FDA Approves Pasatru For Adults With Fibrodysplasia Ossificans Progressiva ]]>
pharmexec.com
/1 month ago
<![CDATA[Pharmaceutical Executive Daily: FDA Approves Orezeyful]]>
pharmexec.com
/1 month ago
<![CDATA[FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma]]>
pharmexec.com
/1 month ago
<![CDATA[FDA Issues CRL to Elevar Therpaeutics for Combination of Rivoceranib and Camrelizumab ]]>
pharmexec.com
/5 days ago
<![CDATA[FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults ]]>
pharmexec.com
/4 weeks ago
<![CDATA[The Significance of FDA’s First Warning Letter for Inappropriate Use of AI]]>
pharmexec.com
/1 month ago
<![CDATA[FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia ]]>
pharmexec.com
/1 month ago
<![CDATA[Pharmaceutical Executive Daily: FDA Grants Traditional Approval to Novartis's Fabhalta]]>
pharmexec.com
/3 weeks ago
<![CDATA[President Trump Set to Nominate Heidi Overton as FDA Commissioner ]]>
pharmexec.com
/1 month ago
<![CDATA[FDA's New Frontier: Drug Pricing Enters the Conversation]]>
pharmexec.com
/1 month ago
<![CDATA[FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease]]>
pharmexec.com
/1 month ago
<![CDATA[FDA Approves Orezeyful for Narcolepsy Type 1 in Adults ]]>
pharmexec.com
/1 month ago
<![CDATA[Pharmaceutical Executive Daily: FDA Approves Lipfendra]]>
pharmexec.com
/1 month ago
<![CDATA[Pharmaceutical Executive Daily: FDA Approves Simtriyo]]>
pharmexec.com
/1 month ago
<![CDATA[FDA Approves Fabhalta to Slow Kidney Function Decline in Primary IgAN in Adults ]]>
pharmexec.com
/1 month ago
<![CDATA[FDA Grants Emergency Use Authorization for Seegene’s Multiplex PCR Assay ]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering <![Cdata[Fda]]>
pharmexec.com
Recent coverage from public sources
Public source